Aileron Therapeutics, Inc. (ALRN)  Description, Stock price, News & Info.

#ThinkSabio Latest News

Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)